AzurRx BioPharma, Inc. (AZRX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 85 transactions totaling $1.7M, demonstrating a bearish sentiment with -$292.5K in net insider flow. The most recent transaction on Mar 19, 2020 involved a transaction of 9,000 shares valued at $0.
No significant insider buying has been recorded for AZRX in the recent period.
No significant insider selling has been recorded for AZRX in the recent period.
Based on recent SEC filings, insider sentiment for AZRX is bearish with an Insider Alignment Score of 42/100 and a net flow of -$292.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at AzurRx BioPharma, Inc. (AZRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading AZRX stock, having executed 85 transactions in the past 90 days. The most active insider is Edmund Burke Ross Jr (Executive), who has made 7 transactions totaling $5.4M.
Get notified when executives and directors at AZRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 19, 2020 | J. Casamento Charles | Executive | Gift | 9,000 | $N/A | $0 | |
| Mar 19, 2020 | J. Casamento Charles | Executive | Gift | 9,000 | $N/A | $0 | |
| Mar 11, 2020 | Lee Schramm Vern | Executive | Award | 8,414 | $1.04 | $8.8K | |
| Mar 11, 2020 | Lee Schramm Vern | Executive | Award | 14,584 | $0.60 | $8.8K | |
| Mar 11, 2020 | J. Casamento Charles | Executive | Award | 14,584 | $0.60 | $8.8K | |
| Mar 11, 2020 | J. Casamento Charles | Executive | Award | 8,414 | $1.04 | $8.8K | |
| Mar 11, 2020 | Riddell Alastair | Executive | Award | 264 | $4.74 | $1.3K | |
| Mar 11, 2020 | Riddell Alastair | Executive | Award | 770 | $4.74 | $3.6K | |
| Mar 11, 2020 | Riddell Alastair | Executive | Award | 2,755 | $3.63 | $10.0K | |
| Mar 11, 2020 | Riddell Alastair | Executive | Award | 14,584 | $0.60 | $8.8K | |
| Mar 11, 2020 | Riddell Alastair | Executive | Award | 8,414 | $1.04 | $8.8K | |
| Mar 11, 2020 | Riddell Alastair | Executive | Award | 2,507 | $3.99 | $10.0K | |
| Mar 10, 2020 | Borkowski Edward | Executive | Award | 8,414 | $1.04 | $8.8K | |
| Mar 10, 2020 | Borkowski Edward | Executive | Award | 14,584 | $0.60 | $8.8K | |
| Mar 10, 2020 | Borkowski Edward | Executive | Award | 1,319 | $4.74 | $6.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 1 | $4.8M | 65.4% |
Sale(S) | 4 | $1.0M | 13.9% |
Purchase(P) | 9 | $727.5K | 9.9% |
Award(A) | 61 | $514.0K | 7.0% |
Exercise(M) | 6 | $180.0K | 2.5% |
Exercise (Options)(X) | 1 | $100.0K | 1.4% |
Gift(G) | 3 | $0 | 0.0% |
Insider activity at AzurRx BioPharma, Inc. shows mixed signals across all time. While $727.5K in purchases indicates some executive confidence,$1.0M in sales balances the picture, resulting in a modest net flow of -$292.5K.11 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Edmund Burke Ross Jr, has transacted $5.4M during this period.